Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
about
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinomaStrategies for early detection of resectable pancreatic cancerAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaReview of screening for pancreatic cancer in high risk individualsNew-onset diabetes: a potential clue to the early diagnosis of pancreatic cancerPancreatic cancer stem cell markers and exosomes - the incentive pushMicroRNA in pancreatic ductal adenocarcinoma and its precursor lesionsEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerEarly diagnosis of pancreatic cancer: challenges and new developmentsPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersRole of endoscopic ultrasound in the diagnosis of pancreatic cancerTumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progressionEpidemiology of pancreatic cancerEarly detection of pancreatic cancer: why, who, and how to screenA Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.Screening for Pancreatic Cancer.Extraintestinal Applications of Endoscopic Ultrasound.Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Pancreatic cancer.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.[Early pancreatic cancer: can the methods currently available identify this disease?].The differential diagnosis of chronic pancreatitis.Importance of age of onset in pancreatic cancer kindredsScreening and detection of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Absence of deleterious palladin mutations in patients with familial pancreatic cancer.Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.Patient perspective on the value of genetic counselling for familial pancreas cancerSerum fatty acid synthase as a marker of pancreatic neoplasiaRisk of pancreatic cancer in families with Lynch syndrome.Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancerScreening for pancreatic cancer: why, how, and who?Genetic predisposition to pancreatic cancer.MicroRNA alterations of pancreatic intraepithelial neoplasiasPancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Pancreatic adenocarcinomaEpidemiology of pancreatic cancer and the role of family historyNovel methylation biomarker panel for the early detection of pancreatic cancer.The early diagnosis of pancreatic cancer and diabetes: what's the relationship?
P2860
Q21144653-58454E21-1E0C-4A53-AEFA-4BC805686729Q24564006-97A0C57A-B118-44BD-8B94-4E2C4621FF8DQ24627680-E0BC372E-06D7-4DC0-A66D-C27FDE76CE71Q24630198-C87BB4C1-105C-4228-A410-050DC07FC693Q24656132-8661C6A3-4A78-49AE-BB7B-A1BD036118B6Q26741215-F8CA5169-DC9C-412B-998B-4A2D5DEF9571Q26769953-EA5448A9-4712-40DA-8CB7-8F0620C85A79Q27010209-AB6B4CD5-8A73-4FB1-B07E-997B8C83BB6DQ27014027-D6CE879D-69FB-4713-BE5F-727583BA057EQ27022231-5E698066-EC8D-4753-AF79-9D44DAE9FFDFQ27027629-975F61A7-45A2-4935-BF01-04ABEBDD1B53Q28072763-912C429E-0EB8-4FC2-9684-0A68E63444C0Q28079456-47046440-6A0F-4AD2-9E8D-79B34E6BEF22Q28295036-25FBE5A4-5CDF-4104-B5CC-ED1C654E0C2BQ30238706-312A6C2F-8416-44AA-8E9A-3ED724975D13Q30240971-2B06974E-D202-454D-B8BC-165EBA4C9CB4Q30361300-5EBDDEDD-166D-426B-AABA-E9B9DD2219E1Q30368922-CB873ADF-FA8D-481D-BDE7-040728C509C8Q30490247-7E67ECA4-E446-4B76-AB32-60B1DA7957FFQ30504615-D0DC6C48-51C6-4628-869A-FC329377A1DEQ30512754-2EEF35C3-9B02-4F30-B3D2-33C63DEBDB2DQ30541314-176CD64A-093E-4F76-8FFA-AFFF973B441AQ33351295-82067DD6-0970-470A-9D1A-1729D2820B0FQ33461453-37FDABC7-BB3D-4D77-B856-CADA17A51C14Q33598358-DA4BB323-8CB5-4B05-9A0E-E284755D9E21Q33666350-47215BD1-E744-4CBB-89C2-963B38428D8EQ33668716-FEBAAFC2-FA66-4FA1-B01A-E11F9EC9D6BFQ33699291-0C0440FF-B6A1-40F2-9A12-E38C53193F59Q33722522-B26CDF57-6B85-4AC7-8812-8F0FB3111A6FQ33814875-BDC6642D-FAAE-4DF3-9193-C467379C76D5Q33880380-04845C04-C952-400C-92CA-39DBAC275BE6Q33924966-68226390-814C-45E7-ACE2-8D1C5C19D028Q33959412-C9480A79-F106-49BC-88A7-5D06450E666AQ34067868-A5159FAB-DE0D-4B46-A342-7ACB64694DCBQ34082610-37A5F4D2-52EC-42C9-869C-3D8A9BF06239Q34093790-3112A4AA-9C1E-4D13-A81D-9C627F931AEEQ34140498-469E8568-77DF-435F-8996-44E092DBD1D9Q34155002-8082130B-9413-4EC4-AFF1-04F2C7E4747EQ34374959-6DB1F2C6-4FCF-4913-ADE8-55E7EC687C55Q34450178-090F290F-9501-469B-A5F3-8E14D2939F66
P2860
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@en
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@nl
type
label
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@en
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@nl
prefLabel
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@en
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@nl
P2093
P50
P1476
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
@en
P2093
Charles J Yeo
Constance Griffin
Elliot K Fishman
Francis M Giardiello
Gloria M Petersen
Jennifer E Axilbund
Kieran Brune
Marcia Irene Canto
Sanjay Jagannath
Syed Z Ali
P304
P356
10.1016/S1542-3565(04)00244-7
P407
P577
2004-07-01T00:00:00Z